News & Updates

Once-weekly semaglutide for T2D good enough in real-world use

02 Jul 2021 by

A once-weekly dosing of the glucagon-like peptide-1 receptor agonist (GLP-1RA) semaglutide for type 2 diabetes (T2D) passes muster in real world, conferring benefits for blood sugar and weight across adult patients with varying characteristics and background medication, according to the Denmark (DK)/Sweden (SE) data from the SURE programme.

Once-weekly semaglutide for T2D good enough in real-world use

02 Jul 2021

Fenofibrate cardioprotective, cuts risk of death in T2D

01 Jul 2021

In patients with type 2 diabetes (T2D), treatment with fenofibrate appears to lower the incidence of cardiovascular events, as well as the rate of total and cardiac mortality, according to data from a large study.

Fenofibrate cardioprotective, cuts risk of death in T2D

01 Jul 2021

$Cabozantinib a new SoC for previously treated RAI-refractory DTC?$

Cabozantinib a new SoC for previously treated RAI-refractory DTC?

30 Jun 2021 by

In individuals with radio-iodine-refractory differentiated thyroid cancer (RAI-refractory DTC) who have progressed during/after prior VEGFR-targeted therapy, the VEGFR2/MET/AXL/RET inhibitor cabozantinib showed a significant progression-free survival (PFS) benefit, according to findings of the phase III COSMIC-311 trial presented at ASCO 2021.

Cabozantinib a new SoC for previously treated RAI-refractory DTC?

30 Jun 2021

DPP-4 inhibitors a suitable second-line treatment for young-onset diabetes

30 Jun 2021

In the treatment of patients with young-onset diabetes, adding dipeptidyl peptidase-4 (DPP-4) inhibitors contributes to lower risks of hospitalization and death compared with sulfonylureas, according to a study.

DPP-4 inhibitors a suitable second-line treatment for young-onset diabetes

30 Jun 2021

Weight-loss surgery slims down cancer risk in NAFLD patients

29 Jun 2021 by

Nonalcoholic fatty liver disease (NAFLD) patients with morbid obesity who undergo bariatric surgery are less likely to develop cancer than their peers who did not go through the procedure, as shown in a study.

Weight-loss surgery slims down cancer risk in NAFLD patients

29 Jun 2021

Plant-based protein diet lowers serum urate in gout patients

29 Jun 2021

A Dietary Approaches to Stop Hypertension (DASH)-style diet with an emphasis on plant-based protein reduces serum urate relative to that rich in carbohydrates or unsaturated fat, reports a recent study.

Plant-based protein diet lowers serum urate in gout patients

29 Jun 2021

Resistance exercise helps reduce obesity risk

29 Jun 2021 by

Individuals who do resistance exercise (RE) have a significantly lower risk of developing obesity regardless of whether one meets the aerobic exercise (AE) guidelines, suggests a study. However, those who meet both the RE and AE guidelines show the lowest risk of obesity.

Resistance exercise helps reduce obesity risk

29 Jun 2021

High microbiota-accessible carbohydrates intake improves cardiometabolic risk factors in T2D

29 Jun 2021

Greater intake of microbiota-accessible carbohydrates (MACs) leads to improvement in glycaemic control, blood lipid, body weight, and inflammatory markers for individuals with type 2 diabetes (T2D) relative to lower MACs intake, a study has shown.

High microbiota-accessible carbohydrates intake improves cardiometabolic risk factors in T2D

29 Jun 2021

Most risk factors for premature MI modifiable

28 Jun 2021

Premature myocardial infarction (MI) is associated with risk factors—such as dyslipidaemia and obesity, among others—that can be modified with interventions, according to the results of a systematic review and meta-analysis.

Most risk factors for premature MI modifiable

28 Jun 2021

Early pregnancy HbA1c pinpoints women at risk of birthing LGA infants

26 Jun 2021

For pregnant women, having HbA1c levels ≥5.6 percent early in pregnancy is linked to a heightened risk of having a large-for-gestational-age (LGA) newborn, according to a study.

Early pregnancy HbA1c pinpoints women at risk of birthing LGA infants

26 Jun 2021

News & Updates

Filter by Specialty:

Specialty:

Once-weekly semaglutide for T2D good enough in real-world use

Once-weekly semaglutide for T2D good enough in real-world use

Fenofibrate cardioprotective, cuts risk of death in T2D

Fenofibrate cardioprotective, cuts risk of death in T2D

Cabozantinib a new SoC for previously treated RAI-refractory DTC?

Cabozantinib a new SoC for previously treated RAI-refractory DTC?

DPP-4 inhibitors a suitable second-line treatment for young-onset diabetes

DPP-4 inhibitors a suitable second-line treatment for young-onset diabetes

Weight-loss surgery slims down cancer risk in NAFLD patients

Weight-loss surgery slims down cancer risk in NAFLD patients

Plant-based protein diet lowers serum urate in gout patients

Plant-based protein diet lowers serum urate in gout patients

Resistance exercise helps reduce obesity risk

Resistance exercise helps reduce obesity risk

High microbiota-accessible carbohydrates intake improves cardiometabolic risk factors in T2D

High microbiota-accessible carbohydrates intake improves cardiometabolic risk factors in T2D

Most risk factors for premature MI modifiable

Most risk factors for premature MI modifiable

Early pregnancy HbA1c pinpoints women at risk of birthing LGA infants

Early pregnancy HbA1c pinpoints women at risk of birthing LGA infants